Cancer Early Detection & Diagnostics at Massachusetts General Hospital provides specialized screening, diagnostic evaluation and advanced testing to help identify cancer as early as possible or investigate suspicious findings. Depending on the patient's age, risk factors and symptoms, evaluation may include screening tests, imaging, laboratory testing, biopsy and pathology review.
Price on Request
Why Price on Request?
The cost depends on the type of screening or diagnostic test, imaging, laboratory work, pathology, biopsy and specialist consultation required. A personalized estimate is provided according to the patient's evaluation plan.
Cancer Early Detection & Diagnostics focuses on identifying cancer at an early stage and investigating abnormalities that may indicate cancer.
Services may include:
Cancer screening
Diagnostic imaging
Laboratory testing
Biopsy
Pathology
Molecular testing
Specialist evaluation
Evaluation may be appropriate for people with:
Increased cancer risk
A strong family history
Previous cancer
Suspicious symptoms
Abnormal screening results
Abnormal imaging
Unexplained findings requiring further evaluation
Screening tests are designed to identify certain cancers or precancerous conditions before symptoms develop.
Screening recommendations depend on:
Age
Personal history
Family history
Risk factors
Previous screening
Specific cancer risk
When an abnormality is identified, specialists may perform additional evaluation to determine whether cancer is present.
This may include:
Physical examination
Blood tests
Imaging
Biopsy
Pathology review
Depending on the suspected cancer, diagnostic imaging may include:
CT scan
MRI
PET scan
Ultrasound
Mammography
X-ray
Other specialized imaging
When appropriate, a biopsy may be performed to obtain tissue for examination.
Pathologists evaluate the sample to determine:
Whether cancer is present
Cancer type
Tumor characteristics
Other relevant pathological findings
Laboratory and pathology services can support cancer diagnosis and treatment planning.
Testing may help evaluate:
Blood-cell counts
Organ function
Tumor-related markers
Tissue characteristics
Molecular features
Selected tumors may undergo molecular testing to identify characteristics that can help guide treatment.
Testing may evaluate:
Genetic alterations
Molecular changes
Tumor biomarkers
Potential treatment targets
Some patients may benefit from evaluation of inherited cancer risk.
Depending on personal and family history, specialists may consider:
Genetic counseling
Genetic testing
Risk assessment
Personalized screening recommendations
Patients at increased risk of cancer may receive individualized recommendations for surveillance and diagnostic evaluation.
Risk may be associated with:
Family history
Previous cancer
Genetic factors
Certain medical conditions
Other established risk factors
Patients previously treated for cancer may require follow-up testing to monitor for possible recurrence.
Monitoring may include:
Clinical examinations
Imaging
Laboratory testing
Disease-specific surveillance
Complex cases may involve specialists from:
Medical oncology
Surgical oncology
Radiation oncology
Pathology
Radiology
Genetics
Other specialized cancer programs
Patients with an existing diagnosis may seek a second opinion involving review of:
Pathology
Biopsy results
Imaging
Laboratory reports
Molecular testing
Previous treatment recommendations
International patients should provide available medical records whenever possible.
Useful documents may include:
Previous screening reports
Biopsy results
Pathology reports
CT/MRI/PET reports
Laboratory results
Genetic testing
Previous cancer treatment records
Medication list
Comprehensive diagnostic services may help:
Detect certain cancers earlier
Investigate suspicious findings
Confirm a diagnosis
Determine cancer type
Establish disease stage
Identify relevant biomarkers
Guide treatment planning
Support cancer surveillance
Massachusetts General Hospital provides comprehensive cancer diagnosis and early-detection services through Mass General Cancer Center, supported by specialized pathology, radiology, oncology and multidisciplinary diagnostic expertise.
Price: Price on Request
Potential costs may include:
Screening consultation
Diagnostic consultation
Imaging
Laboratory testing
Biopsy
Pathology
Molecular testing
Genetic counseling or testing
Follow-up consultation
A personalized cost estimate should be requested according to the patient's diagnostic requirements.
Cancer early detection aims to identify certain cancers before they become advanced, often through recommended screening or evaluation of early symptoms and abnormal findings.
No. Screening recommendations depend on age, risk factors, personal history and the specific type of cancer.
For many cancers, a biopsy is used to confirm the diagnosis, but the exact diagnostic approach varies by cancer type.
Yes. Specialists can review previous imaging, pathology and diagnostic reports as part of further evaluation or a second opinion.
Price is available on request. The final cost depends on the screening or diagnostic tests, imaging, pathology and consultations required.
Product Name: Cancer Early Detection & Diagnostics at Massachusetts General Hospital
Hospital: Massachusetts General Hospital
Brand: Massachusetts General Hospital
Country: United States
Specialty: Oncology & Cancer Care
Service Type: Cancer Early Detection & Diagnostics
Customer-Facing Price: Price on Request
International Patients: Available
Location: Boston, Massachusetts, USA
Frequently Bought Together
Products from this Seller
View All
Subscribe our newsletter for coupon, offer and exciting promotional discount..
Share with Friends
Trading is more effective when you share products with friends!Share you link
Share to